Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Clinical trial NCT03006770 · COMPLETED
Trial details
- NCT number
- NCT03006770
- Sponsor
- Pluristem Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2021-03-03
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.